An MTT assay was used to determine the viability of NSCLC cells. Briefly, BEAS-2B and H460 cells, A549 and SK-MES-1 cells were transfected with PTEN-shRNA or negative control shRNA for 48, 72 or 96 h. Cells were subsequently incubated at 37°C with 20 µl of MTT (5 mg/ml) for 4 h and the purple crystals were dissolved in dimethylsulfoxide for 15 min. A total of 150 µl/well was transferred into 96-well plates and the absorbance was measured using a microplate reader at 490 nm (iMark Microplate Reader; Bio-Rad Laboratories, Inc., Hercules, CA, USA). The inhibition rate was calculated using Microsoft Excel software 2016 (Microsoft Corporation, Redmond, WA, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.